These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3708154)

  • 1. Purification of Hageman factor (factor XII) on columns of popcorn-agarose.
    Ratnoff OD; Everson B; Donaldson VH; Mitchell BH
    Blood; 1986 Jun; 67(6):1550-3. PubMed ID: 3708154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Hageman factor (factor XII) by popcorn inhibitor.
    Kambhu SA; Ratnoff OD; Everson B
    J Lab Clin Med; 1985 May; 105(5):625-8. PubMed ID: 3989356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid purification with high recovery of factor XII (Hageman factor) on immunoaffinity column: application to an abnormal clotting factor XII (factor XIITORONTO).
    Takahashi I; Saito H
    J Biochem; 1988 Apr; 103(4):641-3. PubMed ID: 3139646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of human factor XII from plasma using zinc chelate affinity chromatography.
    Pixley RA; Colman RW
    Thromb Res; 1986 Jan; 41(1):89-98. PubMed ID: 3634525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of C1(-)-inhibitors from normal persons and patients with type II hereditary angioneurotic edema with purified activated Hageman factor (factor XIIa).
    Donaldson VH; Mitchell BH; Everson B; Ratnoff OD
    Blood; 1990 Feb; 75(4):911-21. PubMed ID: 2302459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and properties of an abnormal Hageman factor (Factor XII) molecule in a cross-reacting material-positive hageman trait plasma.
    Saito H; Scialla SJ
    J Clin Invest; 1981 Oct; 68(4):1028-35. PubMed ID: 6793628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of beta-XIIa (Hageman factor fragment) from human plasma.
    Tankersley DL; Alving BM; Finlayson JS
    Thromb Res; 1982 Feb; 25(4):307-17. PubMed ID: 6978550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on factor XII in porcine plasma: purification and its conversion to activated form by porcine plasma kallikrein.
    Mashiko H; Kato K; Fujii K; Takahashi H
    Biochim Biophys Acta; 1996 Sep; 1296(2):198-206. PubMed ID: 8814227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monoclonal antibody that inhibits activation of human Hageman factor (factor XII).
    Small EJ; Katzmann JA; Tracy RP; Ratnoff OD; Goldsmith GH; Everson B
    Blood; 1985 Jan; 65(1):202-10. PubMed ID: 3965048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated human Hageman factor (XII).
    Speer RJ; Ridgway H; Hill JM
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):1-11. PubMed ID: 16955961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and characterization of a murine monoclonal antibody against a heavy chain of Hageman factor (factor XII).
    Saito H; Ishihara T; Suzuki H; Watanabe T
    Blood; 1985 May; 65(5):1263-8. PubMed ID: 3922451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor XII: Hageman factor.
    Pixley RA; Colman RW
    Methods Enzymol; 1993; 222():51-65. PubMed ID: 8412813
    [No Abstract]   [Full Text] [Related]  

  • 13. Purification of human blood clotting factor X by Blue Dextran agarose affinity chromatography.
    Vician L; Tishkoff GH
    Biochim Biophys Acta; 1976 May; 434(1):199-208. PubMed ID: 938663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isolation, purification, and properties of factor XII and its active fragment (beta-XIIa)].
    Blokhina TB; Neshkova EA; Iarovaia GA
    Vopr Med Khim; 2002; 48(6):603-10. PubMed ID: 12698561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of bovine factor XII (Hageman factor).
    Fujikawa K; Walsh KA; Davie EW
    Biochemistry; 1977 May; 16(10):2270-8. PubMed ID: 861210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of C1 inhibitor. A new approach for the isolation of this biologically important plasma protease inhibitor.
    Prograis LJ; Hammer CH; Katusha K; Frank MM
    J Immunol Methods; 1987 May; 99(1):113-22. PubMed ID: 3553333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hageman factor fragment inhibitor in corn seeds: purification and characterization.
    Hojima Y; Pierce JV; Pisano JJ
    Thromb Res; 1980 Oct; 20(2):149-62. PubMed ID: 6782698
    [No Abstract]   [Full Text] [Related]  

  • 18. Purification and properties of a single-chain urokinase-type plasminogen activator form produced by subcultured human umbilical vein endothelial cells.
    Booyse FM; Lin PH; Traylor M; Bruce R
    J Biol Chem; 1988 Oct; 263(29):15139-45. PubMed ID: 3170576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purified factor XII has a higher specific activity than the parent molecule in plasma.
    Wuillemin WA; Furlan M; Huber I; Lämmle B
    Thromb Haemost; 1991 Feb; 65(2):169-73. PubMed ID: 2053104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-step chromatographic procedure for purification of basic fibroblast growth factor from recombinant Escherichia coli and characterization of the equilibrium parameters of adsorption.
    Seeger A; Rinas U
    J Chromatogr A; 1996 Oct; 746(1):17-24. PubMed ID: 8885384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.